RBC Capital Sticks to Their Buy Rating for Penumbra (PEN)
TipRanksApr 17 15:59
Piper Sandler Remains a Buy on Penumbra (PEN)
TipRanksApr 12 20:29
Penumbra Analyst Ratings
BenzingaApr 3 23:36
Piper Sandler Reiterates Overweight on Penumbra, Maintains $290 Price Target
BenzingaApr 3 23:38
Penumbra Analyst Ratings
BenzingaMar 22 21:20
Positive Outlook for Penumbra: Accelerated THUNDER Trial Progress and Thunderbolt System Potential Justify Buy Rating
TipRanksMar 19 18:16
Penumbra's Growth Trajectory and Market Dominance Reinforce Buy Rating
TipRanksMar 4 21:15
Piper Sandler Cuts Inari to Neutral; Cites Slowing Growth, DOJ Probe
Seeking AlphaMar 2 05:03
Analysts Offer Insights on Healthcare Companies: Penumbra (PEN), Jazz Pharmaceuticals (JAZZ) and Argenx Se (ARGX)
TipRanksMar 1 18:04
Piper Sandler Adjusts Price Target on Penumbra to $290 From $310, Maintains Overweight Rating
MT NewswiresFeb 27 00:51
Buy Rating Justified by Penumbra's Market Presence and Projected Growth
TipRanksFeb 26 12:35
Penumbra Analyst Ratings
BenzingaFeb 24 02:34
Deutsche Bank Raises Penumbra Price Target to $288 From $257, Maintains Buy Rating
MT NewswiresFeb 23 23:38
Analysts' Opinions Are Mixed on These Healthcare Stocks: Penumbra (PEN), BioMarin Pharmaceutical (BMRN) and Insulet (PODD)
TipRanksFeb 23 20:51
Maintaining Buy Rating on Penumbra: Strong Growth Prospects and Strategic Focus
TipRanksFeb 23 20:35
Analysts Are Bullish on Top Healthcare Stocks: Collegium Pharmaceutical (COLL), Penumbra (PEN)
TipRanksFeb 23 20:31
Penumbra Analyst Ratings
BenzingaFeb 23 19:15
Analysts Offer Insights on Healthcare Companies: Intra-Cellular Therapies (ITCI), Penumbra (PEN) and BioMarin Pharmaceutical (BMRN)
TipRanksFeb 23 19:10
Hold Rating on Penumbra: Balancing Operational Strengths and Market Expectations
TipRanksFeb 23 18:45
Buy Rating Affirmed: Penumbra's Strong Product Pipeline and Technological Advancements Set to Drive Growth
TipRanksFeb 6 18:37
No Data
No Data